Effcacy and Safety of Tacalcitol and Calcitriol on Vitiligo:A Systematic Review
WU Yan,LIU Yu-bo,LIU Jia-li,DONG Guang-hui,XU Yuan-yuan,LI Yuan-hong,GAO Xing-hua,CHEN Hong-Duo
2009-01-01
Abstract:Objective To assess the efficacy and safety of tacalcitol and calcitriol on vitiligo. Methods We searched the MEDLINE (1966 to June 2008), Cochrane Central Register of Controlled Trials (The Cochrane Library, issue 4, 2008), OVID (1978 to June 2008), EMbase (1980 to June 2008), CBM (1978 to June 2008), CNKI (1979 to June 2008) to collect randomized controlled trials (RCTs). We also hand searched relevant journals and conference proceedings. The language was con ned to English and Chinese. We screened the retrieved studies according to the prede ned inclusion and exclusion criteria, evaluated the quality of included studies, and performed meta-analyses by using the Cochrane Collaboration’s RevMan 4.2 software. Results Ffiteen trials involving 120 patients in 5 self-control trials and 793 patients in other 10 randomized controlled trials were included and assessed. The time of repigmentation onset of good responders and normal responders in the side treated with a combination of topical talcitol and NB-UVB was shorter than that in the control group [WMD= – 75, 95%CI (– 93.93, – 56.07); WMD= – 48, 95%CI (– 76.36, – 19.64)]. The mean number and cumulative dose of excimer light exposures for initial repigmentation in the side treated with tacalcitol and 308-nm monochromatic excimer light were less than those in the control group [WMD= – 0.78, 95%CI (– 1.02, – 0.54; WMD= – 1.06, 95%CI (– 1.36, – 0.76)]. The mean number of UVA exposures for initial repigmentation and complete repigmentation in the side treated with calcipotriol and PUVA were less than those in the control group [WMD= – 2.67,95%CI (– 3.06, – 2.28); WMD= – 2.67, 95%CI (– 3.42, – 1.92)], and the cumulative UVA dose for iniitial and complete repigmentation in the combination group were also lower than those in the control group [WMD= – 25.68, 95%CI (– 29.44, – 21.92); WMD= – 27.14, 95%CI (– 34.80, – 19.48)]. The mean time of initial pigmentation was much shorter in the group treated with calcipotriol and corticosteroid was shorter than that in the control group [WMD= – 3.87, 95%CI (– 5.45, – 2.29)]. Conclusion The limited evidence indicated that combination of topical tacalcitol with NB-UVB or monochromatic excimer light, or the combination of topical calcipotriol with PUVA or corticosteroid shortened the time of repigmentation and decreased the cumulative irradiation dose. The side effects were limited. No obvious effect was seen on re-pigmentation degree.